Krsnaa Diagnostics Limited (BOM:543328)

Market Cap	24.97B
Revenue (ttm)	6.97B
Net Income (ttm)	756.57M
Shares Out	n/a
EPS (ttm)	22.81
PE Ratio	33.01
Forward PE	n/a
Dividend	2.50 (0.31%)
Ex-Dividend Date	Sep 13, 2024

Volume	2,967
Average Volume	3,499
Open	810.00
Previous Close	802.85
Day's Range	792.85 - 814.80
52-Week Range	527.55 - 1,041.80
Beta	n/a
RSI	46.45
Earnings Date	May 30, 2025

About Krsnaa Diagnostics

Krsnaa Diagnostics Limited provides diagnostic services in India. It offers various diagnostic services, including radiology, pathology, and teleradiology services. The company also provides health packages, such as diagnostic testing packages for diabetes, heart health, liver health, kidney health, thyroid, fatigue, cancer, senior citizen care, bone health, infection screening, fever profiles, etc. It serves its services to public and private hospitals, medical colleges, and community health centers. Krsnaa Diagnostics Limited was incorporated...

• Industry: Medical Laboratories
• Founded: 2010
• Employees: 3,700
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 543328

Financial Performance

In 2023, Krsnaa Diagnostics's revenue was 6.20 billion, an increase of 27.20% compared to the previous year's 4.87 billion. Earnings were 568.37 million, a decrease of -8.49%.